日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immunogenicity of Sulfated Lactosyl Archaeol Archaeosome-Adjuvanted Versus Non-Adjuvanted SARS-CoV-2 Spike Booster Vaccines in Young and Aged Balb/c Mice

在年轻和年老的Balb/c小鼠中,硫酸乳糖基古菌醇佐剂与非佐剂SARS-CoV-2刺突蛋白加强疫苗的免疫原性比较

Stark, Felicity C; Akache, Bassel; Renner, Tyler M; Agbayani, Gerard; Deschatelets, Lise; Dudani, Renu; Harrison, Blair A; Hemraz, Usha D; Régnier, Sophie; Stuible, Matthew; Durocher, Yves; McCluskie, Michael J

A Safe and Accessible Cell-Based Spike-ACE2 Binding Assay for Evaluating SARS-CoV-2 Neutralization Activity in Biological Samples Using Flow Cytometry

一种安全易行的基于细胞的刺突蛋白-ACE2结合检测方法,用于利用流式细胞术评估生物样本中SARS-CoV-2的中和活性

Martin A Rossotti ,Shannon Ryan ,Greg Hussack ,Jamshid Tanha ,Bassel Akache ,Tyler M Renner

Modifying the glycosylation profile of SARS-CoV-2 spike-based subunit vaccines alters focusing of the humoral immune response in a mouse model.

改变 SARS-CoV-2 刺突蛋白亚单位疫苗的糖基化特征,可以改变小鼠模型中体液免疫反应的集中程度

Renner Tyler M, Stuible Matthew, Rossotti Martin A, Rohani Nazanin, Cepero-Donates Yuneivy, Sauvageau Janelle, Deschatelets Lise, Dudani Renu, Harrison Blair A, Baardsnes Jason, Koyuturk Izel, St Michael Frank, Hill Jennifer J, Hemraz Usha D, Lenferink Anne E G, Tanha Jamshid, Fernandes Barbara, Roldao Antonio, McCluskie Michael J, Akache Bassel, Durocher Yves

Sulfated lactosyl archaeol (SLA) archaeosomes as a vaccine adjuvant

硫酸化乳糖基古菌醇(SLA)古菌体作为疫苗佐剂

Akache, Bassel; McCluskie, Michael J

Self-amplifying RNAs generated with the modified nucleotides 5-methylcytidine and 5-methyluridine mediate strong expression and immunogenicity in vivo

利用修饰核苷酸5-甲基胞苷和5-甲基尿苷生成的自扩增RNA在体内介导强烈的表达和免疫原性。

Azizi, Hiva; Renner, Tyler M; Agbayani, Gerard; Simard, Bryan; Dudani, Renu; Harrison, Blair A; Iqbal, Umar; Jia, Yimei; McCluskie, Michael J; Akache, Bassel

Tuning the immune response: sulfated archaeal glycolipid archaeosomes as an effective vaccine adjuvant for induction of humoral and cell-mediated immunity towards the SARS-CoV-2 Omicron variant of concern

调节免疫反应:硫酸化古细菌糖脂古菌体作为有效的疫苗佐剂,可诱导针对 SARS-CoV-2 Omicron 变体的体液和细胞介导免疫

Tyler M Renner, Bassel Akache, Matthew Stuible, Nazanin Rohani, Yuneivy Cepero-Donates, Lise Deschatelets, Renu Dudani, Blair A Harrison, Jason Baardsnes, Izel Koyuturk, Jennifer J Hill, Usha D Hemraz, Sophie Régnier, Anne E G Lenferink, Yves Durocher, Michael J McCluskie

Blood-Based Immune Protein Markers of Disease Progression in Murine Models of Acute and Chronic Inflammatory Bowel Disease

急性和慢性炎症性肠病小鼠模型中疾病进展的血液免疫蛋白标志物

Tyler Milston Renner, Gerard Agbayani, Renu Dudani, Michael J McCluskie, Bassel Akache

Effectiveness of VSV vectored SARS-CoV-2 spike when administered through intranasal, intramuscular or a combination of both

VSV载体SARS-CoV-2刺突蛋白经鼻内、肌内或两者联合给药时的有效性

Saina Beitari ,Gerard Agbayani ,Melissa Hewitt ,Diana Duque ,Jegarubee Bavananthasivam ,Jagdeep K Sandhu ,Bassel Akache ,Ita Hadžisejdić ,Anh Tran

Preclinical evaluation of manufacturable SARS-CoV-2 spike virus-like particles produced in Chinese Hamster Ovary cells

在中国仓鼠卵巢细胞中生产可制造的 SARS-CoV-2 刺突病毒样颗粒的临床前评估

Sergio P Alpuche-Lazcano, Matthew Stuible, Bassel Akache, Anh Tran, John Kelly, Sabahudin Hrapovic, Anna Robotham, Arsalan Haqqani, Alexandra Star, Tyler M Renner, Julie Blouin, Jean-Sébastien Maltais, Brian Cass, Kai Cui, Jae-Young Cho, Xinyu Wang, Daria Zoubchenok, Renu Dudani, Diana Duque, Michae

Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern

源自令人担忧的 Beta 和 Delta 变体的 SARS-CoV-2 刺突抗原的免疫原性

Bassel Akache, Tyler M Renner, Matthew Stuible, Nazanin Rohani, Yuneivy Cepero-Donates, Lise Deschatelets, Renu Dudani, Blair A Harrison, Christian Gervais, Jennifer J Hill, Usha D Hemraz, Edmond Lam, Sophie Régnier, Anne E G Lenferink, Yves Durocher, Michael J McCluskie